Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Biofrontera Inc. Warrants (BFRIW)

Pharmaceutical Preparations

https://www.biofrontera-us.com

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

120 PRESIDENTIAL WAY,, SUITE 330
WOBURN, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/29/2021

Market Cap

5,436,157

Shares Outstanding

1,370,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.4700

Last Div

0.0000

Range

0.0431-0.0431

Chg

0.0131

Avg Vol

N/A

Mkt Cap

5436157

Exch

NASDAQ

Country

US

Phone

781-245-1325

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.1820

EV Multiple

-0.1938

P/FV

587.9484

Div Yield %

0.0000

P/E

-474.8412

PEG

-50.4421

Payout

0.0000

Current Ratio

1.8851

Quick Ratio

1.4593

Cash Ratio

0.4725

DSO

36.2980

DIO

77.5684

Op Cycle

113.8664

DPO

47.4335

CCC

66.4329

Gross Margin

0.4730

Op Margin

-0.5399

Pretax Margin

-0.3830

Net Margin

-0.3834

Eff Tax Rate

-0.0012

ROA

-0.6262

ROE

-4.7713

ROCE

-1.5458

NI/EBT

1.0012

EBT/EBIT

0.7094

EBIT/Rev

-0.5399

Debt Ratio

0.0667

D/E

0.1320

LT Debt/Cap

0.0390

Total Debt/Cap

0.1166

Int Coverage

-15.6826

CF/Debt

-9.8576

Equity Multi

1.9773

Rec Turnover

10.0557

Pay Turnover

7.6950

Inv Turnover

4.7055

FA Turnover

26.4726

Asset Turnover

1.6332

OCF/Share

-0.0028

FCF/Share

-0.0028

Cash/Share

0.0009

OCF/Sales

-0.4029

FCF/OCF

1.0034

CF Coverage

-9.8576

ST Coverage

-14.2377

CapEx Coverage

-295.7292

Div&CapEx Cov

-295.7292

P/BV

587.9484

P/B

587.9484

P/S

0.1820

P/E

-474.8412

P/FCF

-0.4502

P/OCF

-451.9271

P/CF

-451.9271

PEG

-50.4421

P/S

0.1820

EV Multiple

-0.1938

P/FV

587.9484

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation